Positive phase II double-blind randomized placebo-controlled crossover trial of clemastine fumarate for remyelination of chronic optic neuropathy in MS

Authors
Category Primary study
JournalNeurology
Year 2016
This article has no abstract
Epistemonikos ID: cddc19bfb7c167ece1ea6eac5945838fc99ff174
First added on: Feb 07, 2025